Article

Innovative Trial Approaches in Immune-Mediated Inflammatory Diseases: Current Use and Future Potential

2020-09-15

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Despite progress that has been made in the treatment of many immune-mediated inflammatory diseases (IMIDs), there remains a need for improved treatments. Randomised controlled trials (RCTs) provide the highest form of evidence on the effectiveness of a potential new treatment regimen, but they are extremely expensive and time consuming to conduct. Consequently,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0c0cce1c-d14a-5931-8231-1832691ce8e6
DOI: 10.21203/rs.3.rs-63613/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Innovative Trial Approaches in Immune-Mediated Inflammatory Diseases: Current Use and Future PotentialDOI 10.21203/rs.3.rs-63613/v1Read

Methodological review to develop a list of bias items for adaptive clinical trials: Protocol and rationaleSemantic proximity Read

The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeuticsSemantic proximity Read

A quantitative systems pharmacology workflow towards optimal design and biomarker stratification of atopic dermatitis clinical trialsSemantic proximity Read

Preexisting autoimmune disease is a risk factor for immune-related adverse events: a meta-analysisSemantic proximity Read

Examining the Feasibility and Functionality of Common Analysis Methods for Longitudinal Data with Binary OutcomesSemantic proximity Read

Resist the Temptation of Response-Adaptive RandomizationSemantic proximity Read

Anakinra for dengue patients with hyperinflammation: protocol for a randomized double-blind placebo-controlled trialSemantic proximity Read

The Call for Progress in Evidence-Based MedicineSemantic proximity Read

A general framework for using two-stage meta-analysis with individual participant data to predict individualized treatment effectsSemantic proximity Read

Two Stage Designs for Phase III Clinical TrialsSemantic proximity Read

Part II: Adaptive designs in pediatric clinical trials: specific examples, comparison with adult trials and a discussion for the child health communitySemantic proximity Read

Do we need to adjust for interim analyses in a Bayesian adaptive trial design?Semantic proximity Read